Home >> Marketplace Directory >> Neurodevelopmental genetic tests, 3/16

Neurodevelopmental genetic tests, 3/16

image_pdfCreate PDF

 

March 2016—Ambry Genetics has launched a suite of five genetic tests for neurodevelopmental conditions: IDNext, a broad panel of 140 genes known to be associated with both syndromic and nonsyndromic intellectual disability; AutismFirst, a targeted panel of 16 genes recognized by the American College of Genetics and Genomics as associated with syndromic autism spectrum disorders; AutismNext, a broader panel of 48 genes that can cause both syndromic and nonsyndromic ASDs; Neurodevelopment-Expanded, a broad panel of 196 genes designed for patients who have a combination of ID, ASDs, and epilepsy; and Rett/AngelmanNext, a panel of 22 genes known to cause symptoms of multiple overlapping neurodevelopmental disorders, including Rett syndrome and Angelman syndrome.

Ambry Genetics, 949-900-5500

CAP TODAY
X